Navigation Links
Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP
Date:12/13/2012

etic disease in which the patient inherits a mutant gene that produces a misfolded form of TTR, which progressively accumulates in tissues, impairing their function.  In patients with transthyretin amyloidosis, both the mutant and normal forms of TTR can build up as fibrils in tissues, including heart, peripheral nerves, and the gastrointestinal tract.  The presence of TTR aggregates interferes with the normal functions of these tissues, and as the TTR protein aggregates enlarge more tissue damage occurs and the disease worsens.  There are two common types of transthyretin amyloidosis, familial amyloid cardiomyopathy, or FAC, which affects more than 40,000 patients worldwide, and FAP, which affects more than 10,000 patients worldwide.  Patients with FAC have TTR build up in the heart muscle and succumb to heart failure five to six years after symptom onset.  Patients with FAP have TTR build up in peripheral nerve tissue leading to the loss of nerve function and wasting.  ISIS-TTRRx is an investigational drug that is designed to inhibit the production of all forms of TTR, and could offer an alternative approach to treat all types of transthyretin-related amyloidosis. 

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
2. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
3. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
4. Mylan Announces Pricing of Senior Notes
5. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
6. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
7. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
8. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
9. River Vision Announces Completion of $17 million Series A Financing
10. Winner Medical Announces Closing of Going Private Transaction
11. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)...  Over the next five years, the marijuana industry in ... predicting that 14 more states will legalize recreational marijuana and ... for legal cannabis grew 74 percent in 2014 to $2.7 ... market could grow more than fourfold to $11 billion in ... on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) is ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... 2nd edition" report to their offering. ... perspectives from 130 patient groups with an interest in ... companies (and of the pharma industry as a whole) ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ... Reputation of Pharma in 2014 - a Perspective of ... to their offering. For the first time, ... corporate reputation of the pharmaceutical industry held by patient ... views of patient organisations representing all therapy areas. ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... PRUSSIA, Pa., May 1, 2012  Medical Alarm Concepts Holding, ... agreement with several holders of its convertible debt. Under ... has been cancelled, preventing a significant amount of common ... of another 13,750,000 million warrants, bringing the total number ...
... Acella Pharmaceuticals, LLC, announces the addition of Tom ... of their commercial team. Tom will lead the ... line.    Tom is a highly ... than 11 years of industry experience, including sales, ...
Cached Medicine Technology:MDHI in Agreement with Debt Holders - Portion of Convertible Debt and Additional 14M Warrants Cancelled -- Total of 101M Warrants Cancelled this Year 2
(Date:4/18/2015)... Beverly Hills, CA (PRWEB) April 19, 2015 ... cherish and will proudly display for the rest of their ... and money obtaining them and put in a great amount ... gotten on a whim, they have outgrown them or simply ... 20 percent of people regret their tattoo, and in 2012-13 ...
(Date:4/18/2015)... released a new blog post explaining how to find ... damage. , Clients can now find auto insurance plans ... intentionally on fire. This type of damages can be linked ... , It is possible to compare the best online car ... in just a few minutes. Clients should always review multiple ...
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining ... insurance prices . , Drivers who live in ... have to pay more for auto insurance plans that ... also offer protection against vehicle theft. , Affordable ... a single website: http://lowcostcarinsuranceprice.com/ . Drivers who ...
(Date:4/18/2015)... More than 2000 styles of newly designed ... #1 online store carrying celebrity inspired special occasion dresses. ... their perfect dresses for their prom. For those who ... at TheCelebrityDresses.com would be an ideal choice. , ... dresses inspired by the most loved styles seen at ...
(Date:4/18/2015)... Canada (PRWEB) April 18, 2015 French ... emotions on food choices when he uttered, “Tell me ... you are.” Using food to cope with stress or ... by Queendom.com indicates otherwise. Data collected from ... genders fall victim to emotional eating, but for different ...
Breaking Medicine News(10 mins):Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... , , More than 45 million Americans suffer from headaches ... up with the National Headache Foundation (NHF), EHE International is helping ... annually. In a unique approach, the NHF and EHE are ... 115 square-foot display window at 10 Rockefeller Plaza, for the month ...
... CVD ) today announced that it will present at William ... 9, 2009 at 4:50 p.m. (ET). Investors may access ... . In order to register and download any necessary software, ... Covance, with headquarters in Princeton, New Jersey, is one of the ...
... groups issued the following statement regarding the upcoming FDA ... , As advocates for people living with mental ... the importance of viable treatment options for bipolar disorder ... to safe and effective treatments, including more information about ...
... under-represented in clinical cancer research published in high-impact journals, ... University of Michigan Comprehensive Cancer Center. Taking into ... women, studies included a smaller proportion of women than ... of cancer types that were not gender specific, including ...
... Continua Health Alliance Design Guidelines , , SAN ... ZigBee(R) Alliance announced today that the Continua Health Alliance ... power local area network (LAN) standard. ZigBee Health Care ... a single network. Continua recommends ZigBee for sensing and ...
... Pa., June 8 ViroPharma Incorporated (Nasdaq: VPHM ... to its board of directors. , , Dr. Baldino ... and leadership to ViroPharma. He is the chief executive ... Inc., an international biopharmaceutical company in Chester County, Pennsylvania. ...
Cached Medicine News:Health News:EHE International Supports the National Headache Foundation 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 3Health News:Women underrepresented in cancer research, U-M study finds 2Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 2Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 3Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 2Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 3
Inquire...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
Medicine Products: